Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100044310Phase 4Recruiting
Phase 4, randomised trial of esketamine in Reduced lung compliance and Hypoxemia (2 arms), sponsored by Reproductive Hospital affiliated with Shandong University. Primary endpoints: Oxygenation index, Peak airway pressure and 1 more. Started Mar 2021; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100044310.